Knight Therapeutics, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 11.50% vs 9.55% in Dec 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 48.31% vs 334.21% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "148.40",
          "val2": "133.10",
          "chgp": "11.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "26.80",
          "val2": "21.30",
          "chgp": "25.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.60",
          "val2": "3.90",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.00",
          "val2": "8.90",
          "chgp": "-122.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.20",
          "val2": "8.90",
          "chgp": "48.31%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.30%",
          "val2": "46.70%",
          "chgp": "2.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 21.22% vs 13.13% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -225.58% vs 125.60% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "450.10",
          "val2": "371.30",
          "chgp": "21.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "54.40",
          "val2": "60.60",
          "chgp": "-10.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "10.40",
          "val2": "9.20",
          "chgp": "13.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.50",
          "val2": "-11.60",
          "chgp": "78.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-5.40",
          "val2": "4.30",
          "chgp": "-225.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4.90%",
          "val2": "20.20%",
          "chgp": "-2.51%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

148.40

133.10

11.50%

Operating Profit (PBDIT) excl Other Income

26.80

21.30

25.82%

Interest

2.60

3.90

-33.33%

Exceptional Items

-2.00

8.90

-122.47%

Consolidate Net Profit

13.20

8.90

48.31%

Operating Profit Margin (Excl OI)

71.30%

46.70%

2.46%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is 11.50% vs 9.55% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is 48.31% vs 334.21% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

450.10

371.30

21.22%

Operating Profit (PBDIT) excl Other Income

54.40

60.60

-10.23%

Interest

10.40

9.20

13.04%

Exceptional Items

-2.50

-11.60

78.45%

Consolidate Net Profit

-5.40

4.30

-225.58%

Operating Profit Margin (Excl OI)

-4.90%

20.20%

-2.51%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 21.22% vs 13.13% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -225.58% vs 125.60% in Dec 2024

All Annual Results